PapRIV, a BV-2 microglial cell activating quorum sensing peptide

Yorick Janssens1, Nathan Debunne1, Anton De Spiegeleer1,2,3

  • 1Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.

Scientific Reports
|May 22, 2021
PubMed

Insights

Bacterial quorum sensing peptides (QSPs) like PapRIV can cross the gut-brain barrier. This peptide activates microglia, suggesting a role in gut-brain communication and neuroinflammation.

Area of Science:

  • Microbiology
  • Neuroscience
  • Immunology

Background:

  • Quorum sensing peptides (QSPs) are bacterial signaling molecules with potential host effects.
  • The gut-brain axis links gut microbiota to microglial function.
  • Microglia play a crucial role in brain immunity and function.

Purpose of the Study:

  • To investigate the microglial activating properties of the QSP PapRIV from Bacillus cereus.
  • To determine if PapRIV can cross the gastro-intestinal tract and blood-brain barrier.
  • To explore PapRIV's role in gut-brain interactions.

Main Methods:

  • In vitro studies using BV-2 microglia cells and Caco-2 cell models.
  • In vivo assessment of peptide presence in mouse plasma.
  • Analysis of cytokine (IL-6, TNFα) and ROS expression.
  • NF-κB pathway activation assessment.
  • Metabolite identification in serum.

Main Results:

  • PapRIV demonstrated in vitro activation of BV-2 microglia cells.
  • PapRIV successfully crossed the Caco-2 cell model and was detected in mouse plasma, indicating BBB penetration.
  • PapRIV induced IL-6, TNFα, and ROS expression in a NF-κB dependent manner.
  • A major active metabolite of PapRIV was identified in serum.

Conclusions:

  • PapRIV can traverse the gastro-intestinal tract and blood-brain barrier.
  • PapRIV exhibits microglia-activating properties in vitro.
  • These findings suggest a potential role for PapRIV in modulating gut-brain axis communication and neuroinflammation.